Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
T. NISHIDA (Tokyo, Japan), Y. Matsumoto (Tokyo, Japan), M. Tanaka (Tokyo, Japan), T. Nakai (Tokyo, Japan), Y. Ohe (Tokyo, Japan), S. Watanabe (Tokyo, Japan), N. Motoi (Tokyo, Japan). Feasibility study of cryobiopsy for practical pathological diagnosis including immunohistochemical assessment of primary lung cancer. 2769

Member's Comments

No comment yet.

Related content which might interest you: Evaluate of radiological, bronchoscopical and histopathological features of patients with primary lung cancer Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Clinical management implications of histologic information provided by lung biopsy in the multidisciplinary evaluation of interstitial lung diseases. Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020 The diagnostic relevance of cytologic examination of induced sputum in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 299s Year: 2004 The role of bronchoscopy in the diagnosis of lung cancer: an audit to assess standards Source: Eur Respir J 2001; 18: Suppl. 33, 62s Year: 2001 Contribution of immunological examination to the diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 65s Year: 2001 Bronchoscopic techniques in diagnosis and staging of lung cancer Source: Breathe 2011; 7: 324-337 Year: 2011 Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Bronchoscopic findings in lung cancer: diagnostic yield of specimen collection method compared to histological type Source: Eur Respir J 2005; 26: Suppl. 49, 534s Year: 2005 Cytological diagnostics of lung cancer: our experience Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005 Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013 Feasibility of intraoperative imprint cytology for evaluation of N status in lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 367s Year: 2003 Patient perspectives and experience on the diagnostic pathway of lung cancer – a qualitative study Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care Year: 2018 Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse lung disease Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 Clinical usefulness of autofluorescence bronchoscopy in the early detection of lung cancer in a general hospital Source: Eur Respir J 2001; 18: Suppl. 33, 6s Year: 2001 Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases Year: 2021 Prognostic validation of cryobiopsy for the diagnosis of interstitial lung diseases Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound Year: 2019 The role of radial endobronchial ultrasound for peripheral lung cancer tissue sampling and prognostic biomarkers analysis – a single-center retrospective study Source: International Congress 2019 – Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration Year: 2019 The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer Source: Eur Respir J 2006; 28: 915-919 Year: 2006